Skip to Content

Dr. Reeder and colleagues awarded highly competitive challenge grant as part of ARRA

Posted on Nov 2, 2009

Dr. Scott Reeder and colleagues were awarded a $1 million NIH grant through the American Recovery and Reinvestment Act to improve treatment of patients with hepatocellular carcinoma using innovative new MRI techniques. The team will use a non-invasive method that uses magnetic resonance imaging (MRI) to measure blood flow (perfusion) in hepatocellular carcinoma (HCC). The team will use the new method to determine whether anti-angiogenic drugs used to treat these tumors are effective. Currently, patients must undergo 2-3 months of anti-angiogenic therapy, which can be toxic and is expensive, in order to determine whether the drug is effective against the tumor. Using the new perfusion MRI methods, Dr. Reeder and his team aim to determine the efficacy of the drug in 2 days. In this way, the prolonged use of ineffective, toxic and expensive drugs can be avoided and alternative therapies pursued. Co-investigators include William Schelman, MD, PhD from Oncology, Sean Fain, PhD from Medical Physics and Radiology, and Wally Block, PhD from Biomedical Engineering and Radiology.

More news:

3rd Annual University of Wisconsin Interventional Radiology Symposium

Breast Imaging Section Leadership Announcement

NIH Continues Funding for Dr. Reeder’s Liver Disease Research

Dr. David Bluemke Presents Stanford University Grand Rounds

Dr. Avey Selected As ASNR Outreach Professor

Aunt Minnie Features UW CT Time Efficiency Study

Dr. Jeannine Ruby Completes ABC News Resident Rotation Program

Faculty and Alumni Gather at RSNA 2017

UW Badger Radiologists to Leave Mark on RSNA 2017

Last updated: 1/19/2018
Feedback, questions, or accessibility issues:
© 2018 The Board of Regents of the University of Wisconsin System